Header Logo

Connection

JASVINDER SINGH to Triazoles

Back to Details
This is a "connection" page, showing publications JASVINDER SINGH has written about Triazoles.
JASVINDER SINGH
Connection Strength
0.554
Triazoles
  1. Filgotinib, a JAK1 Inhibitor, for Treatment-Resistant Rheumatoid Arthritis. JAMA. 2019 07 23; 322(4):309-311.
    View in: PubMed
    Score: 0.150
  2. Cardiovascular Disease in Gout and the?Protective Effect of Treatments Including Urate-Lowering Therapy. Drugs. 2019 Apr; 79(5):531-541.
    View in: PubMed
    Score: 0.147
  3. Response to: 'A response to Singh. "Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?"' by Valiyil and Schechter. Ann Rheum Dis. 2018 07; 77(7):e42.
    View in: PubMed
    Score: 0.132
  4. Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer? Ann Rheum Dis. 2017 05; 76(5):779-781.
    View in: PubMed
    Score: 0.126
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.